Registry for patients with heart conditions and treatments

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Cardiology Research Dubrava registry is a prospective, single-center initiative that collects data from patients with various heart conditions, including acute coronary syndrome, heart failure, and atrial fibrillation. It focuses on patients who have received specific treatments such as SGLT-2 inhibitors, TAVI implantation, and anticoagulation therapy. The registry aims to monitor clinical status, laboratory results, bleeding complications, and major cardiovascular events over the long term. This comprehensive data collection will help improve understanding and management of these conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria: patients implanted with CIED, or with VTE, or with ACS or with TAVI -

Exclusion Criteria: non compliance, not undergoing follow-up at this center

\-

Where it's running

• Dubrava University Hospital
  Zagreb, Croatia Recruiting

Study contacts

• Principal investigator: Irzal Hadzibegovic, M.D. — Dubrava University Hospital
• Study coordinator: Ivan Zeljkovic, M.D.
• Email: kardio@kbd.hr
• Phone: 00385917823289

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding brain and heart injuries after bleeding in the brain

  This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT06906432

• Common femoral vein-to-artery diameter ratio to detect elevated LVEDP

  Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.

  Recruiting Burapha University · Chon Buri · NCT07866859

• Intrahospital flu vaccine for adults with high cardiovascular risk when admitted for ACS or heart failure

  This study tests whether offering a flu vaccine at the bedside during a hospital stay, along with counseling, increases vaccination rates for adults with acute coronary syndrome or heart failure who are at high cardiovascular risk.

  Recruiting at 2 sites University Hospital of Cologne · Cologne and 1 other locations · NCT07721649

• Volta AI software in real-world AF ablation

  A real-world observational study will test the latest Volta AF-Xplorer II AI software during atrial fibrillation ablation to see how safe and effective it is over 24 months.

  Recruiting Volta Medical · Marseille and 2 other locations · NCT07621055

• Village-doctor–led telehealth care to improve outcomes for AF and HF in older adults

  A village doctor–led telemedicine program will try to improve heart failure management in rural AF patients aged 65–80 compared with usual care.

  Recruiting at 3 sites Jiangsu Taizhou People's Hospital · Yancheng, Dongtai and 2 other locations · NCT07492524

• Village doctor–led telehealth care to prevent heart failure in AF patients

  A village doctor–led telehealth program tests whether integrated, guideline-based care can help older adults with atrial fibrillation in rural China stay healthier and avoid heart failure compared with usual care.

  Recruiting at 3 sites Jiangsu Taizhou People's Hospital · Yancheng, Dongtai and 2 other locations · NCT07492498

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.